Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEM
Tempus AI
TEM
|
+$693M |
| 2 |
Reddit
RDDT
|
+$650M |
| 3 |
Applovin
APP
|
+$366M |
| 4 |
Samsara
IOT
|
+$356M |
| 5 |
Dollar General
DG
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.81B |
| 2 |
ONC
BeOne Medicines Ltd
ONC
|
+$988M |
| 3 |
Workday
WDAY
|
+$978M |
| 4 |
Spotify
SPOT
|
+$777M |
| 5 |
Elastic
ESTC
|
+$699M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 31.2% |
| 2 | Technology | 25.57% |
| 3 | Communication Services | 19.74% |
| 4 | Healthcare | 8.44% |
| 5 | Financials | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBR
151
DELISTED
CyberArk
CYBR
| $48M | 0.04% |
117,918
-883
| -0.7% | -$322K |
|
152
Zillow
Z
$7.52B
| $47M | 0.04% |
670,254
-137,075
| -17% | -$9.24M |
|
153
Paychex
PAYX
$42.7B
| $46.3M | 0.03% |
318,223
+138,666
| +77% | +$20.9M |
|
154
Edwards Lifesciences
EW
$51.5B
| $45.6M | 0.03% |
582,598
+1,157
| +0.2% | +$86.3K |
|
155
MP Materials
MP
$8.45B
| $43.8M | 0.03% |
1,317,974
+13,118
| +1% | +$335K |
|
156
Xometry
XMTR
$4.99B
| $43.8M | 0.03% |
1,296,313
+568,032
| +78% | +$16.7M |
|
157
Medtronic
MDT
$110B
| $43M | 0.03% |
492,854
-12,274
| -2% | -$1.04M |
|
158
JFrog
FROG
$10.1B
| $42.7M | 0.03% |
973,397
-87,761
| -8% | -$3.33M |
|
159
MarketAxess Holdings
MKTX
$5.72B
| $41.7M | 0.03% |
186,689
-34,551
| -16% | -$7.59M |
|
|
EXAS
160
DELISTED
Exact Sciences
EXAS
| $41.5M | 0.03% |
780,016
-52,552
| -6% | -$2.67M |
|
161
McDonald's
MCD
$196B
| $39.8M | 0.03% |
136,286
-7,742
| -5% | -$2.39M |
|
162
Warby Parker
WRBY
$3.31B
| $39.5M | 0.03% |
1,801,620
-26,144
| -1% | -$483K |
|
163
Cognex
CGNX
$11.3B
| $37.1M | 0.03% |
1,168,992
-46,633
| -4% | -$1.34M |
|
164
Ginkgo Bioworks
DNA
$555M
| $36.9M | 0.03% |
3,276,051
-74,840
| -2% | -$580K |
|
165
AbCellera Biologics
ABCL
$1.99B
| $35.5M | 0.03% |
10,360,004
-835,828
| -7% | -$2.08M |
|
166
Transmedics
TMDX
$2.78B
| $35.2M | 0.03% |
262,961
+3,284
| +1% | +$361K |
|
|
CRCL
167
Circle Internet Group
CRCL
$16.1B
| $34.3M | 0.03% |
+189,085
| New | +$30.8M |
|
168
LiveRamp
RAMP
$2.3B
| $34.3M | 0.03% |
1,037,266
-274,757
| -21% | -$7.98M |
|
169
Trupanion
TRUP
$1.24B
| $33.2M | 0.02% |
599,110
-78,926
| -12% | -$3.5M |
|
170
dLocal
DLO
$4.35B
| $30.6M | 0.02% |
2,699,607
+97,044
| +4% | +$955K |
|
171
Appian
APPN
$2.23B
| $30M | 0.02% |
1,006,201
-69,997
| -7% | -$2.1M |
|
172
Twist Bioscience
TWST
$6.84B
| $28.5M | 0.02% |
775,687
+43,680
| +6% | +$1.51M |
|
173
IPG Photonics
IPGP
$3.69B
| $28.2M | 0.02% |
411,007
+41,134
| +11% | +$2.57M |
|
174
Progyny
PGNY
$2.37B
| $27.9M | 0.02% |
1,267,134
-9,033
| -0.7% | -$198K |
|
175
Sana Biotechnology
SANA
$949M
| $27.5M | 0.02% |
10,064,728
-126,748
| -1% | -$262K |
|
Similar funds
Baillie Gifford & Co's Q2 2025 Portfolio in Review
As of Q2 2025, Baillie Gifford & Co held 284 positions worth $134B, up 17% from $115B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Baillie Gifford & Co withdrew a net $6.67B in Q2 2025, closing 20 positions and reducing 175 holdings. Its most notable exit was BeOne Medicines Ltd, an estimated $988M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 33% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Baillie Gifford & Co opened a new position in Tempus AI worth $768M.
- Baillie Gifford & Co's largest Q2 2025 buy was Tempus AI: 12,094,029 shares worth $768M.
- Baillie Gifford & Co added most to Reddit in Q2 2025, an estimated $650M increase.
- Baillie Gifford & Co's biggest Q2 2025 reduction was Shopify, cutting an estimated $1.81B.
- Baillie Gifford & Co fully exited BeOne Medicines Ltd in Q2 2025, selling an estimated $988M.
- Baillie Gifford & Co's ten largest holdings make up 46% of its $134B portfolio in Q2 2025.
- Baillie Gifford & Co opened 19 new positions and closed 20 in Q2 2025.
- Baillie Gifford & Co's portfolio value rose 17% quarter-over-quarter to $134B.
Based on Baillie Gifford & Co's 13F filing for Q2 2025, filed 6 Aug 2025.